EUVIMEDEUVIMED entdecken
Crossref

Response-adapted surgery after neoadjuvant immunotherapy in head and neck squamous cell carcinoma

Carla Cantaffa, Carlo Resteghini, Fabio Ferreli, Paolo Bossi, Giuseppe Spriano, Alberto Paderno

Academia Oncology · 15.07.2026 · 3 (3)

DOI: 10.20935/acadonco8417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Oncology, online erschienen am 15.07.2026. Verfasst von Carla Cantaffa und 5 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As neoadjuvant immunotherapy becomes established as a reference framework in head and neck squamous cell carcinoma management, opportunities emerge to tailor both surgical extent and timing according to treatment response. Spatial regression patterns, in addition to depth of response, should guide extent adaptation, with more conservative surgery considered for patients exhibiting a centripetal regression pattern, provided that intraoperative frozen sections from the pretreatment tumor edges are negative, potentially sparing clinically meaningful structures (e.g., avoiding mandibulectomy in oral cavity cancer). Despite promising preliminary evidence from single-center cohorts, prospective validation of the oncological feasibility and functional benefit of limited resections, supported by protocolized reporting of which structures are spared, remains necessary. Nodal management is more controversial due to frequent discordance between primary tumor and nodal response, as well as the high rate of false-positive post-treatment positron emission tomography (PET) findings. Most neoadjuvant immunotherapy trials have reported no or limited surgical delays; however, the role of response-adapted timing of surgery is under investigation, as early responders may benefit from additional immunotherapy cycles, provided that non-responders can be rapidly expedited to surgery.

Zitieren

APA

Cantaffa, C., Resteghini, C., Ferreli, F., Bossi, P., Spriano, G., & Paderno, A. (2026). Response-adapted surgery after neoadjuvant immunotherapy in head and neck squamous cell carcinoma. Academia Oncology, 3(3). https://doi.org/10.20935/acadonco8417

Vancouver

Cantaffa C, Resteghini C, Ferreli F, Bossi P, Spriano G, Paderno A. Response-adapted surgery after neoadjuvant immunotherapy in head and neck squamous cell carcinoma. Academia Oncology. 2026;3(3). doi:10.20935/acadonco8417

BibTeX
@article{Cantaffa2026,
  author = {Cantaffa, Carla and Resteghini, Carlo and Ferreli, Fabio and Bossi, Paolo and Spriano, Giuseppe and Paderno, Alberto},
  title = {Response-adapted surgery after neoadjuvant immunotherapy in head and neck squamous cell carcinoma},
  journal = {Academia Oncology},
  year = {2026},
  volume = {3},
  number = {3},
  doi = {10.20935/acadonco8417}
}
Kostenlos starten →